Narcolepsy Material Market 2027 by Types, Application, Technology, Opportunities, End Users and Regions | The Insight Partners

Narcolepsy Market to 2027 - Global Analysis and Forecasts by Type (Narcolepsy with Cataplexy, Narcolepsy without Cataplexy, and Secondary Narcolepsy); Product (Central Nervous System (CNS) Stimulants, Sodium Oxybate, and Antidepressants); Distribution Channel (Hospital Pharmacies and Retail Pharmacies) and Geography

Publication Month: Feb 2019 | Report Code: TIPRE00003326 | No. of Pages: 156 | Category: Pharmaceuticals | Status: Published

The global narcolepsy market accounted to US$ 2,026.8 Mn in 2018 and is expected to grow at a CAGR of 9.5% during the forecast period 2019 – 2027, to account to US$ 4,537.9 Mn by 2027.

The Asia Pacific narcolepsy market is expected to grow at highest rate during the forecast period owing higher number of research & development and increasing investments on sleep related neurological disorders. In addition, emergence of new local players with competitive drug portfolio are expected to fuel the market growth in Asia Pacific region.          

         

Exhibit: Lucrative Regional Markets


Market Insights
Rising prevalence of sleep related neurological disorders is expected to boost the market growth over the years

The range of sleep disorders that are treated by neurologists is wide and includes conditions such as insomnia, sleep apnea, restless legs syndrome, and narcolepsy. These disorders cause disruptions in the normal sleep-wake mechanisms causing endogenous abnormalities. Neurological sleep related disorders is an emerging problem as the population is ageing at a rapid rate. According to the National Institute of Health (NIH), approximately 40 million Americans suffer from neurological diseases in the US, whereas additional 20 million people experience occasional sleeping problems. Over the last decades, much has been learnt about the pathophysiology of narcolepsy. According to the National Center for Biotechnology Information, the prevalence of narcolepsy with cataplexy has been examined in many studies and falls between 25 and 50 per 100,000 people. Moreover, according to the Narcolepsy Network 2017, the condition affects 1 in every 2,000 people in the United States. That’s 200,000 Americans and approximately 3 million worldwide. Moreover, the American Sleep Apnea Association reports that sleep-related problems affect 50 to 70 million Americans of all ages and socioeconomic classes. Sleep disorders are common in both men and women; however, important disparities in prevalence and severity of certain sleep disorders have been identified in minorities and underserved populations. More than 50 million Americans already suffer from over 80 different sleep disorders and another 20 to 30 million suffer intermittent sleep problems each year. The increasing prevalence of neurological sleep disorders and narcolepsy is likely to foster the growth of market in the coming years.

 

Increasing Awareness Regarding Neurological Disorders

The relationship between public health and neurology was not been adequately explored until recent years. The burden of neurological disorders have increased significantly across the world. These disorders are estimated to affect over a billion population worldwide, according to the World Health Organization by 2016. Neurological disorders are commonly found among all the age groups, in all geographic populations.  Similarly, sleep related neurological disorders that comprise a large group of diseases also affect a substantial population worldwide. These diseases majorly includes insomnia, sleep apnea, narcolepsy and others. However, in the recent years, several measures have been undertaken so as to generate awareness and educate the population regarding these diseases, which is likely to propagate patients from accessing the available medications and treatments for these conditions. According to National Center for Biotechnology Information 2017, clinician and public awareness of various sleep disorders with the intent of increasing rates of recognition and treatment. The increasing awareness in patients and initiatives undertaken by non-profit parties is expected to outreach a large patient population regarding the medications available for the disease, thereby favoring the market growth.

 

Type Insights

The narcolepsy market by type is segmented into narcolepsy with cataplexy, narcolepsy without cataplexy, and secondary cataplexy. In 2018, the narcolepsy with cataplexy segment held a largest market share of 65.1% of the narcolepsy market, by type. This segment is also expected to dominate the market in 2027 owing to its significant prevalence among patients suffering with narcolepsy. Episodes of cataplexy are reported to be encountered among 55-60% of patients suffering with narcolepsy. Moreover, the similar segment is anticipated to also witness the fastest growth rate of 9.7% during the forecast period, 2019 to 2027 owing to the increasing demand for drugs to treat the disease.

 

Product Insights

The global narcolepsy market on the basis of product is segmented into sodium oxybate, central nervous system (CNS) stimulants, and antidepressants. Sodium oxybate segment is anticipated to grow at a CAGR of 9.8% during the forecast period. Sodium oxybate is the one of the primary medication recommended by specialists to patients suffering with narcolepsy. The high cost of the branded counterparts, availability of reimbursement with certain regions as well as approval of the drug in majority of the top markets is likely to contribute to the growth and dominance of the segment. Sodium is oxybate is also expected to exhibit highest growth witnessing a robust CAGR over the forecast years.


Exhibit: Narcolepsy Market, by Product


Strategic Insights

Strategic acquisition and product launches were observed as the most adopted strategy in global narcolepsy industry. Few of the recent product launch and acquisitions are listed below:

 

2018: Jazz Pharmaceuticals announced FDA approval of Xyrem (sodium oxybate) for the treatment of cataplexy or excessive daytime sleepiness in pediatric narcolepsy patients

2019: Takeda Pharmaceutical Company Limited acquired Shire plc to expand its geographic footprint and leading position in Japan and the U.S.


2018: Jazz Pharmaceuticals announced FDA acceptance of supplemental new drug application for Xyrem (sodium oxybate) to treat cataplexy and excessive daytime sleepiness in pediatric narcolepsy patients

 

NARCOLEPSY - MARKET SEGMENTATION

 

By Type

  • Narcolepsy with Cataplexy
  • Narcolepsy without Cataplexy
  • Secondary Narcolepsy

 

By Product

  • Central Nervous System (CNS) Stimulants
  • Sodium Oxybate
  • Antidepressants

 

By Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • UK
    • Italy
    • Spain
  • Asia Pacific (APAC)
    • China
    • Japan
    • India
    • Australia
    • South Korea
  • Middle East & Africa (MEA)
    • Saudi Arabia
    • South Africa
    • UAE
  • South America (SAM)
    • Brazil
    • Argentina

 Company Profiles

  • Bioprojet
  • Teva Pharmaceutical Industries Ltd.
  • Jazz Pharmaceuticals, Inc.
  • Graymark Healthcare, Inc.
  • Arena Pharmaceuticals, Inc.
  • Shire (Acquired by Takeda)
  • Ligand Pharmaceuticals, Inc.
  • Novartis AG, Mylan N.V.
  • Shionogi Inc.

1.          INTRODUCTION

1.1    Scope of the Study

1.2    The Insight Partners Research Report Guidance

1.3    market segmentation

1.3.1    Global Narcolepsy Market – By Type

1.3.2    Global Narcolepsy Market – By Product

1.3.3    Global Narcolepsy Market – By Distribution Channel

1.3.4    Global Narcolepsy Market – By Geography

2.          Global Narcolepsy market – Key takeaways

3.          research Methodology

3.1.1    Coverage

3.1.2    Secondary Research

3.1.3    Primary Research

4.          Global narcolepsy market – market landscape

4.1    overview

4.2    pest analysis

4.2.1    North America – PEST Analysis

4.2.2    Europe– PEST Analysis

4.2.3    Asia Pacific– PEST Analysis

4.2.4    Middle East & Africa– PEST Analysis

4.2.5    South and Central America – PEST Analysis

5.          Global Narcolepsy market – Key Market Dynamics

5.1    Key Market Drivers

5.1.1    Rising Prevalence of Sleep Related Neurological Disorders

5.1.2    Emerging Local Pharmaceutical and Biopharmaceutical Companies

5.1.3    Increasing Awareness Regarding Neurological Disorders

5.2    Key Market Restraints

5.2.1    Side Effects and Risks Associated with Narcolepsy Medications

5.2.2    Delayed Diagnosis or Misdiagnosis of Narcolepsy

5.3    Key Market Opportunities

5.3.1    Robust Pipeline Drugs for Narcolepsy

5.4    Future Trends

5.4.1    New Treatments for Narcolepsy

5.5    Impact analysis

6.          Narcolepsy market – Global Analysis

6.1    global Narcolepsy market Revenue Forecasts and Analysis

6.2    global Narcolepsy market, By Geography - Forecasts and Analysis

6.3    PERFORMANCE OF KEY PLAYERS

6.3.1    Jazz Pharmaceuticals plc

6.3.2    Teva Pharmaceutical Industries Ltd.

6.4    Brand Analaysis

6.4.1    Marketed Drugs:

6.4.2    Provigil

6.4.2.1   Overview:

6.4.2.2   Drug Description:

6.4.2.3   Advantages & Disadvantages:

6.4.3    Xyrem

6.4.3.1   Overview:

6.4.3.2   Drug Description:

6.4.3.3   Advantages & Disadvantages:

6.4.4    Nuvigil

6.4.4.1   Overview:

6.4.4.2   Drug Description:

6.4.4.3   Advantages & Disadvantages:

6.5    Pipeline Analysis

7.          Narcolepsy Market Analysis and forecasts to 2027 – type

7.1    Overview

7.2    type market Revenue and Forecasts Analysis (US$ Mn)

7.3    Narcolepsy with cataplexy Market

7.3.1    Overview

7.3.2    Narcolepsy With Cataplexy Market Revenue and Forecast to 2027 (US$ Mn)

7.4    Narcolepsy without cataplexy Market

7.4.1    Overview

7.4.2    Narcolepsy Without Cataplexy Market Revenue and Forecast to 2027 (US$ Mn)

7.5    Secondary Narcolepsy Market

7.5.1    Overview

7.5.2    Secondary Narcolepsy Market Revenue and Forecast to 2027 (US$ Mn)

8.          Narcolepsy Market Analysis and forecasts to 2027 – product

8.1    Overview

8.2    product market Revenue and Forecasts Analysis (US$ Mn)

8.3    central nervous system stimulants Market

8.3.1    Overview

8.3.2    Central Nervous System Stimulants Market Revenue and Forecast to 2027 (US$ Mn)

8.4    sodium oxybate Market

8.4.1    Overview

8.4.2    Sodium Oxybate Market Revenue and Forecast to 2027 (US$ Mn)

8.5    Antidepressants Market

8.5.1    Overview

8.5.2    Antidepressants Market Revenue and Forecast to 2027 (US$ Mn)

9.          Narcolepsy Market Analysis and forecasts to 2027 – Distribution Channel

9.1    Overview

9.2    Distribution Channel market Revenue and Forecasts Analysis (US$ Mn)

9.3    hospital pharmacies Market

9.3.1    Overview

9.3.2    Hospital Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)

9.4    retail pharmacies Market

9.4.1    Overview

9.4.2    Retail Pharmacies Market Revenue and Forecast to 2027 (US$ Mn)

10.        NARCOLEPSY MARKET REVENUE AND FORECASTS TO 2027 – GEOGRAPHICAL ANALYSIS

10.1   north america narcolepsy market

10.1.1  Overview

10.1.2  North America Narcolepsy Market Revenue And Forecasts to 2027 (US$ Mn)

10.1.3  North America Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.4  North America Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.5  North America Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.1.6  North America Narcolepsy Market Revenue And Forecasts to 2027, By Country (%)

10.1.7  US Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8  US Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.8.1 US Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.8.2 US Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.8.3 US Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.1.9  Canada Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.10 Canada Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.10.1 Canada Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.10.2....... Canada Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.10.3....... Canada Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.1.11 Mexico Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.12 Mexico Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.1.12.1. Mexico Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.1.12.2........ Mexico Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.1.12.3........ Mexico Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.2   Europe narcolepsy market

10.2.1  Overview

10.2.2  Europe Narcolepsy market revenue Overview, by Country (2017) (us$ mn)

10.2.3  Europe Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.4  Europe Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.2.5  Europe Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.6  Europe Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.2.7  Europe Narcolepsy market Revenue and Forecasts to 2027, By Country (%)

10.2.8  Germany Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.9  Germany Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.9.1 Germany Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.2.9.2 Germany Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.9.3 Germany Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.2.10 UK Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.11 UK Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.11.1 UK Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.2.11.2. UK Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.11.3............... UK Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.2.12 France Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.13 France Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.13.1 France Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.2.13.2........ France Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.13.3........ France Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.2.14 Italy Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.15 Italy Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.15.1.... Italy Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.2.15.2........... Italy Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.15.3........... Italy Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.2.16 Spain Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.17 Spain Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.2.17.1... Spain Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.2.17.2.......... Spain Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.2.17.3.......... Spain Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.3   ASIA Pacific NARCOLEPSY MARKET

10.3.1  Overview

10.3.2  Asia Pacific Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.3  Asia Pacific Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.3.4  Asia Pacific Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.5  Asia Pacific Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.3.6  Asia Pacific Narcolepsy Market Revenue and Forecasts to 2027, By Country (%)

10.3.7  China Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.8  China Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.8.1 China Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.3.8.2 China Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.8.3 China Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.3.9  Japan Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.10 Japan Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.10.1... Japan Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.3.10.2.......... Japan Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.10.3.......... Japan Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.3.11 India Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.12 India Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.12.1... India Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.3.12.2........... India Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.12.3........... India Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.3.13 Australia Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.14 Australia Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.14.1.... Australia Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.3.14.2.... Australia Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.14.3.... Australia Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.3.15 South Korea Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.16 South Korea Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.3.16.1 South Korea Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.3.16.2 South Korea Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.3.16.3 South Korea Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.4   Middle East & Africa Narcolepsy market

10.4.1  Middle East & Africa Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.2  Middle East & Africa Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.4.3  Middle East & Africa Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.4.4  Middle East & Africa Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel  (US$ Mn)

10.4.5  Middle East & Africa Narcolepsy market Revenue and Forecasts to 2027, By Country (%)

10.4.6  UAE Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.7  UAE Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.7.1 UAE Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.4.7.2 UAE Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.4.7.3 UAE Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.4.8  Saudi Arabia Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.9  Saudi Arabia Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.9.1 Saudi Arabia Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.4.9.2 Saudi Arabia Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.4.9.3 Saudi Arabia Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.4.10 South Africa Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.11 South Africa Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.4.11.1... South Africa Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.4.11.2... South Africa Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.4.11.3... South Africa Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.5   SOUTH AND CENTRAL AMERICA NARCOLEPSY MARKET

10.5.1  Overview

10.5.2  South and Central America Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.3  South & Central America Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.5.4  South & Central America Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.5.5  South & Central America Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.5.6  South and Central America Narcolepsy Market Share by Country, 2017 and 2027 (%)

10.5.7  Brazil Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.8  Brazil Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.8.1 Brazil Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.5.8.2 Brazil Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.5.8.3 Brazil Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

10.5.9  Argentina Narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

10.5.10 Argentina Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)

10.5.10.1... Argentina Narcolepsy Market Revenue And Forecasts to 2027, By Type (US$ Mn)

10.5.10.2... Argentina Narcolepsy Market Revenue And Forecasts to 2027, By Product (US$ Mn)

10.5.10.3... Argentina Narcolepsy Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

11.        Narcolepsy market – Industry Landscape

11.1   Overview

11.2   Comparative Company Analysis

11.3   Growth Strategies in the Narcolepsy market, 2015-2018

11.4   Organic Growth Strategies

11.4.1  Overview

11.4.2  Expansions

11.4.3  Product Launches

11.4.4  Other Organic Growth Strategies

11.5   Inorganic Growth Strategies

11.5.1  Overview

11.5.2  Agreements

11.5.3  Acquisitions

11.5.4  Other Inorganic Growth Strategies

12.        Narcolepsy market –Key company profiles

12.1   Teva Pharmaceutical Industries Ltd.

12.1.1  Key Facts

12.1.2  Business Description

12.1.3  Financial Overview

12.1.4  Product Portfolio

12.1.5  Swot Analysis

12.1.6  Key Developments

12.2   Jazz Pharmaceuticals plc

12.2.1  Key Facts

12.2.2  Business Description

12.2.3  Financial Overview

12.2.4  Product Portfolio

12.2.5  SWOT Analysis

12.2.6  Key Developments

12.3   Arena Pharmaceuticals, Inc.

12.3.1  Key Facts

12.3.2  Business Description

12.3.3  Financial Overview

12.3.4  Product Portfolio

12.3.5  SWOT Analysis

12.3.6  Key Developments

12.4   Graymark Healthcare, Inc.

12.4.1  Key Facts

12.4.2  Business Description

12.4.3  Financial Information

12.4.4  Product Portfolio

12.4.5  SWOT Analysis

12.4.6  Key Developments

12.5   Novartis AG

12.5.1  Key Facts

12.5.2  Business Description

12.5.3  Financial Information

12.5.4  Product Portfolio

12.5.5  SWOT Analysis

12.5.6  Key Developments

12.6   Takeda Pharmaceutical Company Limited

12.6.1  Key Facts

12.6.2  Business Description

12.6.3  Financial Information

12.6.4  Product Pipeline

12.6.5  SWOT Analysis

12.6.6  Key Developments

12.7   Mylan N.V.

12.7.1  Key Facts

12.7.2  Business Description

12.7.3  Financial Overview

12.7.4  Product Portfolio

12.7.5  SWOT Analysis

12.7.6  Key Developments

12.8   BIOPROJET

12.8.1  Key Facts

12.8.2  Business Description

12.8.3  Financial Overview

12.8.4  Product Portfolio

12.8.5  SWOT Analysis

12.8.6  Key Developments

12.9   Shionogi & Co., Ltd.

12.9.1  Key Facts

12.9.2  Business Description

12.9.3  Financial Overview

12.9.4  Product Portfolio

12.9.5  Product Pipeline

12.9.6  SWOT Analysis

12.9.7  Key Developments

12.10 Ligand Pharmaceuticals, Inc.

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Financial Overview

12.10.4 Product Portfolio

12.10.5 Product Pipeline

12.10.6 SWOT Analysis

12.10.7 Key Developments

13.        Appendix

13.1   About The Insight Partners

13.2   Glossary of Terms

 

LIST OF TABLES

TABLE 1.       North America Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 2.       North America Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 3.       North America Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 4.       US Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 5.       US Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 6.       US Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 7.       Canada Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 8.       Canada Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 9.       Canada Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 10.      Mexico Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 11.      Mexico Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 12.      Mexico Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 13.      Europe Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 14.      Europe Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 15.      Europe Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 16.      Germany Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 17.      Germany Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 18.      Germany Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 19.      UK Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 20.      UK Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 21.      UK Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 22.      France Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 23.      France Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 24.      France Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 25.      Italy Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 26.      Italy Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 27.      Italy Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 28.      Spain Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 29.      Spain Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 30.      Spain Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 31.      Asia Pacific Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 32.      Asia Pacific Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 33.      Asia Pacific Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel  (US$ Mn)

TABLE 34.      China Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 35.      China Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 36.      China Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 37.      Japan Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 38.      Japan Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 39.      Japan Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 40.      India Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 41.      India Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 42.      India Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 43.      Australia Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 44.      Australia Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 45.      Australia Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 46.      South Korea Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 47.      South Korea Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 48.      South Korea Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel  (US$ Mn)

TABLE 49.      Middle East & Africa Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 50.      Middle East & Africa Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 51.      Middle East & Africa Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 52.      UAE Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 53.      UAE Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 54.      UAE Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 55.      SAUDI ARABIA Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 56.      SAUDI ARABIA Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 57.      SAUDI ARABIA Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel  (US$ Mn)

TABLE 58.      SOUTH AFRICA Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 59.      SOUTH AFRICA Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 60.      SOUTH AFRICA Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel  (US$ Mn)

TABLE 61.      South & Central America Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 62.      South & Central America Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 63.      South & Central America Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 64.      BRAZIL Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 65.      BRAZIL Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 66.      BRAZIL Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 67.      ARGENTINA Narcolepsy market Revenue And Forecasts to 2027, By Type (US$ Mn)

TABLE 68.      ARGENTINA Narcolepsy market Revenue And Forecasts to 2027, By Product (US$ Mn)

TABLE 69.      ARGENTINA Narcolepsy market Revenue And Forecasts to 2027, By Distribution Channel (US$ Mn)

TABLE 70.      Recent EXPANSIONS in the Narcolepsy market

TABLE 71.      Recent Product Launches in the Narcolepsy market

TABLE 72.      Other Organic Growth Strategies in the Narcolepsy market

TABLE 73.      Recent Agreements in the Narcolepsy market

TABLE 74.      Recent Acquisitions in the Narcolepsy market

TABLE 75.      Recent Other Inorganic Growth Strategies in the Narcolepsy market

TABLE 76.      Glossary of Terms, narcolepsy market

 

LIST OF FIGURES

FIGURE 1.      Narcolepsy market Segmentation

FIGURE 2.      bioreactors Segmentation, by region

FIGURE 3.      Asia Pacific Narcolepsy market, Revenue (US$ Mn), By Geography 2018 & 2027

FIGURE 4.      Global Narcolepsy market By type, Market Share (%), 2018

FIGURE 5.      Global Narcolepsy market By product, Market Share (%), 2018

FIGURE 6.      Global Narcolepsy market By Distribution CHannel, Market Share (%), 2018

FIGURE 7.      North America PEST Analysis

FIGURE 8.      Europe PEST Analysis

FIGURE 9.      Asia pacific PEST Analysis

FIGURE 10.    Middle East & Africa PEST Analysis

FIGURE 11.    South and central america PEST Analysis

FIGURE 12.    Narcolepsy market impact analysis of driver and restraints

FIGURE 13.    global Narcolepsy market – Revenue Forecasts and Analysis –2018- 2027

FIGURE 14.    global Narcolepsy market – by geography Forecasts and Analysis – 2018- 2027

FIGURE 15.    type MARKET Analysis and Forecasts 2018 and 2027 (%)

FIGURE 16.    narcolepsy with cataplexy Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 17.    narcolepsy without cataplexy Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 18.    secondary narcolepsy Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 19.    product MARKET Analysis and Forecasts 2018 and 2027 (%)

FIGURE 20.    central nervous system stimulants Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 21.    sodium oxybate Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 22.    Antidepressants Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 23.    Distribution Channel MARKET Analysis and Forecasts 2018 and 2027 (%)

FIGURE 24.    hospital pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 25.    retail pharmacies Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 26.    North America Narcolepsy market revenue Overview, by Country (2017) (us $ mn)

FIGURE 27.    North America Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 28.    North America Narcolepsy market Revenue And Forecasts to 2027, By Country (%)

FIGURE 29.    US Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 30.    Canada Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 31.    Mexico Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 32.    Europe Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 33.    Europe Narcolepsy market Revenue And Forecasts to 2027, By Country (%)

FIGURE 34.    Germany Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 35.    UK Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 36.    France Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 37.    Italy Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 38.    Spain Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 39.    Asia Pacific Narcolepsy market revenue Overview, by Country (2018) (us $ mn)

FIGURE 40.    Asia Pacific Market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 41.    Asia Pacific Narcolepsy market Revenue And Forecasts to 2027, By Country (%)

FIGURE 42.    China Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 43.    Japan Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 44.    India Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 45.    Australia Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 46.    South Korea Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 47.    Middle East & Africa narcolepsy market REVENUE, by Country, 2018 (US$ MN)

FIGURE 48.    Middle East & Africa Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 49.    Middle East & Africa Narcolepsy market Revenue And Forecasts to 2027, By Country (%)

FIGURE 50.    UAE Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 51.    Saudi Arabia Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 52.    South Africa Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 53.    South and Central America narcolepsy market REVENUE, by Country, 2017 (US$ MN)

FIGURE 54.    South and Central America Narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 55.    South and Central America Narcolepsy market SHARE BY COUNTRY, 2017 AND 2025 (%)

FIGURE 56.    Brazil narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 57.    Argentina narcolepsy market Revenue and Forecasts to 2027 (US$ Mn)

FIGURE 58.    Comparative Company Analysis

FIGURE 59.    Growth Strategies in the Narcolepsy market, 2015-2018

FIGURE 60.    Organic Growth Strategies in the Narcolepsy market, 2015-2018

FIGURE 61.    Inorganic Growth Strategies in the Bioreactor Market, 2015-2018

The List of Companies

  1. Bioprojet
  2. Teva Pharmaceutical Industries Ltd.
  3. Jazz Pharmaceuticals, Inc.
  4. Graymark Healthcare, Inc.
  5. Arena Pharmaceuticals, Inc.
  6. Shire (Acquired by Takeda)
  7. Ligand Pharmaceuticals, Inc.
  8. Novartis AG
  9. Mylan N.V.
  10. Shionogi Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the narcolepsy market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global narcolepsy treatment market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Select License Type
USD $3000
USD $4550
USD $6550
USD $8550